Chang Gung University College of Medicine, Taoyuan, Taiwan; Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Taiwan.
Chang Gung University College of Medicine, Taoyuan, Taiwan.
J Formos Med Assoc. 2017 Nov;116(11):844-851. doi: 10.1016/j.jfma.2017.08.004. Epub 2017 Sep 2.
BACKGROUND/PURPOSE: Acute kidney injury (AKI) developing during extracorporeal membrane oxygenation (ECMO) is associated with very poor outcome. The Kidney Disease: Improving Global Outcomes (KDIGO) group published a new AKI definition in 2012. This study analyzed the outcomes of patients treated with ECMO and identified the relationship between the prognosis and the KDIGO classification.
This study examined total 312 patients initially, and finally reviewed the medical records of 167 patients on ECMO support at a tertiary care university hospital between March 2002 and November 2011. Demographic, clinical, and laboratory variables were retrospectively collected as survival predicators.
The overall mortality rate was 55.7%. In the analysis of the areas under the receiver operating characteristic curves, the KDIGO classification showed relatively higher discriminatory power (0.840 ± 0.032) than the Risk of renal failure, Injury to the kidney, Failure of kidney function, Loss of kidney function, and End-stage renal failure (RIFLE) (0.826 ± 0.033) and Acute Kidney Injury Network (AKIN) (0.836 ± 0.032) criteria in predicting in-hospital mortality. Furthermore, multiple logistic regression analysis showed that KDIGO, hemoglobin, and Glasgow Coma Scale score on the first day of patients on ECMO were independent predictors for in-hospital mortality. Finally, cumulative survival rates at 6-month follow-up after hospital discharge differed significantly for KDIGO stage 3 versus KDIGO stage 0, 1, and 2 (p < 0.001); and KDIGO stage 2 versus KDIGO stage 0 (p < 0.05).
For those patients with ECMO support, the KDIGO classification proved to be a more reproducible evaluation tool with excellent prognostic abilities than RIFLE or AKIN classification.
背景/目的:体外膜肺氧合(ECMO)期间发生的急性肾损伤(AKI)与非常差的预后相关。肾脏疾病:改善全球结局(KDIGO)组织于 2012 年发布了新的 AKI 定义。本研究分析了接受 ECMO 治疗的患者的结局,并确定了预后与 KDIGO 分类之间的关系。
本研究最初检查了 312 例患者,最终回顾了 2002 年 3 月至 2011 年 11 月在一家三级护理大学医院接受 ECMO 支持的 167 例患者的病历。回顾性收集人口统计学、临床和实验室变量作为生存预测因子。
总体死亡率为 55.7%。在接受者操作特征曲线下面积的分析中,KDIGO 分类显示出相对较高的判别能力(0.840±0.032),高于风险衰竭、肾损伤、肾功能衰竭、肾功能丧失和终末期肾病(RIFLE)(0.826±0.033)和急性肾损伤网络(AKIN)(0.836±0.032)标准,可预测住院死亡率。此外,多变量逻辑回归分析表明,KDIGO、血红蛋白和 ECMO 患者入院第一天的格拉斯哥昏迷量表评分是住院死亡率的独立预测因子。最后,出院后 6 个月随访的累积生存率在 KDIGO 第 3 期与 KDIGO 第 0、1 和 2 期之间有显著差异(p<0.001);KDIGO 第 2 期与 KDIGO 第 0 期(p<0.05)之间有显著差异。
对于接受 ECMO 支持的患者,KDIGO 分类被证明是一种更具可重复性的评估工具,具有比 RIFLE 或 AKIN 分类更好的预后能力。